Evaluation of clinical phenotype, survival, and circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Bitting, Rhonda Lynn
Healy, Patrick
Halabi, Susan
George, Daniel J.
Ko, Jung Hyun
Armstrong, Andrew J.
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Duke Univ Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5031
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
    Autio, Karen A.
    Anand, Aseem
    Krupa, Rachel
    Louw, Jessica
    Arslan, Zaina
    Dittamore, Ryan
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [32] Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa
    Bassi, Sunakshi
    Schweizer, Michael Thomas
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [33] The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
    Halabi, Susan
    Guo, Siyuan
    Park, Joseph J.
    Nanus, David M.
    George, Daniel J.
    Antonarakis, Emmanuel S.
    Danila, Daniel Costin
    Szmulewitz, Russell Zelig
    Mcdonnell, Donald P.
    Norris, John D.
    Lu, Changxue
    Luo, Jun
    Armstrong, Andrew J.
    CLINICAL CANCER RESEARCH, 2024, 30 (06) : 1152 - 1159
  • [34] Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer
    Gupta, Santosh
    Halabi, Susan
    Kemeny, Gabor
    Anand, Monika
    Giannakakou, Paraskevi
    Nanus, David M.
    George, Daniel J.
    Gregory, Simon G.
    Armstrong, Andrew J.
    MOLECULAR CANCER RESEARCH, 2021, 19 (06) : 1040 - 1050
  • [35] Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223
    Al-Ezzi, E. M. M.
    Alqaisi, H. A.
    Iafolla, M.
    Sridhar, S.
    Sacher, A.
    Fallah-Rad, N.
    Jiang, D. M.
    Catton, C.
    Warde, P.
    Hamilton, R.
    Fleshner, N.
    Zlotta, A.
    Hansen, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S537 - S538
  • [36] CK- and small nuclear size circulating tumor cell (CTCs) phenotypes in metastatic castration-resistant prostate cancer (mCRPC)
    Ferraldeschi, Roberta
    McDaniel, Andrew
    Krupa, Rachel
    Louw, Jessica
    Tucker, Eric
    Bales, Natalee
    Marrinucci, Dena
    Riisnaes, Ruth
    Mateo, Joaquin
    Dittamore, Ryan
    De Bono, Johann Sebastian
    Tomlins, Scott A.
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [37] Detection and genomic interrogation of circulating tumor cells (CTCs) and circulating tumor stem cells (CTSCs) from men with metastatic castration-resistant prostate cancer (mCRPC)
    Friedlander, Terence W.
    Vy Ngo
    Doty, Shaun
    Zhao, Qiang
    Dong, Huang
    Ryan, Charles J.
    Chen, Wen-Tien
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [38] Detection and Genomic Interrogation of Circulating Tumor Cells (CTCs) and Circulating Tumor Stem Cells (CTSCs) From Men with Metastatic Castration-resistant Prostate Cancer (mCRPC)
    Friedlander, T.
    Ngo, V.
    Doty, S.
    Zhao, Q.
    Dong, H.
    Ryan, C.
    Chen, W.
    Paris, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 152 - 152
  • [39] Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Wetterskog, Daniel
    Scarpi, Emanuela
    Romanel, Alessandro
    Gurioli, Giorgia
    Jayaram, Anuradha
    Lolli, Cristian
    Schepisi, Giuseppe
    Casadei, Chiara
    Menna, Cecilia
    Wingate, Anna
    Demichelis, Francesca
    De Giorgi, Ugo
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Optimal sequencing of enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC)
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa Maria
    Bassi, Sunakshi
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345